Literature DB >> 24419039

Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder.

I Shalev1, T E Moffitt2, A W Braithwaite3, A Danese4, N I Fleming5, S Goldman-Mellor1, H L Harrington1, R M Houts1, S Israel1, R Poulton6, S P Robertson7, K Sugden2, B Williams2, A Caspi2.   

Abstract

There is evidence that persistent psychiatric disorders lead to age-related disease and premature mortality. Telomere length has emerged as a promising biomarker in studies that test the hypothesis that internalizing psychiatric disorders are associated with accumulating cellular damage. We tested the association between the persistence of internalizing disorders (depression, generalized anxiety disorder and post-traumatic stress disorder) and leukocyte telomere length (LTL) in the prospective longitudinal Dunedin Study (n=1037). Analyses showed that the persistence of internalizing disorders across repeated assessments from ages 11 to 38 years predicted shorter LTL at age 38 years in a dose-response manner, specifically in men (β=-0.137, 95% confidence interval (CI): -0.232, -0.042, P=0.005). This association was not accounted for by alternative explanatory factors, including childhood maltreatment, tobacco smoking, substance dependence, psychiatric medication use, poor physical health or low socioeconomic status. Additional analyses using DNA from blood collected at two time points (ages 26 and 38 years) showed that LTL erosion was accelerated among men who were diagnosed with internalizing disorder in the interim (β=-0.111, 95% CI: -0.184, -0.037, P=0.003). No significant associations were found among women in any analysis, highlighting potential sex differences in internalizing-related telomere biology. These findings point to a potential mechanism linking internalizing disorders to accelerated biological aging in the first half of the life course, particularly in men. Because internalizing disorders are treatable, the findings suggest the hypothesis that treating psychiatric disorders in the first half of the life course may reduce the population burden of age-related disease and extend health expectancy.

Entities:  

Mesh:

Year:  2014        PMID: 24419039      PMCID: PMC4098012          DOI: 10.1038/mp.2013.183

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  76 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

Review 2.  Is telomere length a biomarker of aging? A review.

Authors:  Karen Anne Mather; Anthony Francis Jorm; Ruth Adeline Parslow; Helen Christensen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-10-28       Impact factor: 6.053

Review 3.  Potential roles for estrogen regulation of telomerase activity in aging.

Authors:  Sharyn Bayne; Margaret E E Jones; He Li; Jun-Ping Liu
Journal:  Ann N Y Acad Sci       Date:  2007-10       Impact factor: 5.691

4.  Shortened telomeres in individuals with abuse in alcohol consumption.

Authors:  Sofia Pavanello; Mirjam Hoxha; Laura Dioni; Pier Alberto Bertazzi; Rossella Snenghi; Alessandro Nalesso; Santo Davide Ferrara; Massimo Montisci; Andrea Baccarelli
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

5.  Telomere length: a marker of disease susceptibility?

Authors:  Janice K Kiecolt-Glaser; Lisa M Jaremka; Heather M Derry; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2013-08-13       Impact factor: 7.217

Review 6.  Gender differences in posttraumatic stress disorder.

Authors:  Miranda Olff; Willie Langeland; Nel Draijer; Berthold P R Gersons
Journal:  Psychol Bull       Date:  2007-03       Impact factor: 17.737

Review 7.  Stress and telomere biology: a lifespan perspective.

Authors:  Idan Shalev; Sonja Entringer; Pathik D Wadhwa; Owen M Wolkowitz; Eli Puterman; Jue Lin; Elissa S Epel
Journal:  Psychoneuroendocrinology       Date:  2013-04-29       Impact factor: 4.905

8.  Socioeconomic inequalities in depression: a meta-analysis.

Authors:  V Lorant; D Deliège; W Eaton; A Robert; P Philippot; M Ansseau
Journal:  Am J Epidemiol       Date:  2003-01-15       Impact factor: 4.897

Review 9.  Is socioeconomic status associated with biological aging as measured by telomere length?

Authors:  Tony Robertson; G David Batty; Geoff Der; Candida Fenton; Paul G Shiels; Michaela Benzeval
Journal:  Epidemiol Rev       Date:  2012-12-20       Impact factor: 6.222

10.  Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

Authors:  Craig W Colton; Ronald W Manderscheid
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

View more
  79 in total

1.  Depression and telomere length: A meta-analysis.

Authors:  Kathryn K Ridout; Samuel J Ridout; Lawrence H Price; Srijan Sen; Audrey R Tyrka
Journal:  J Affect Disord       Date:  2015-12-02       Impact factor: 4.839

Review 2.  Telomeres, early-life stress and mental illness.

Authors:  Samuel J Ridout; Kathryn K Ridout; Hung-Teh Kao; Linda L Carpenter; Noah S Philip; Audrey R Tyrka; Lawrence H Price
Journal:  Adv Psychosom Med       Date:  2015-03-30

3.  Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls.

Authors:  Naomi M Simon; Zandra E Walton; Eric Bui; Jennifer Prescott; Elizabeth Hoge; Aparna Keshaviah; Noah Schwarz; Taylor Dryman; Rebecca A Ojserkis; Benjamin Kovachy; David Mischoulon; John Worthington; Immaculata De Vivo; Maurizio Fava; Kwok-Kin Wong
Journal:  Psychoneuroendocrinology       Date:  2015-04-13       Impact factor: 4.905

4.  Polygenic risk score of shorter telomere length and risk of depression and anxiety in women.

Authors:  Shun-Chiao Chang; Jennifer Prescott; Immaculata De Vivo; Peter Kraft; Olivia I Okereke
Journal:  J Psychiatr Res       Date:  2018-05-26       Impact factor: 4.791

5.  Sociodemographic correlates of change in leukocyte telomere length during mid- to late-life: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Belinda L Needham; Xu Wang; Judith E Carroll; Sharrelle Barber; Brisa N Sánchez; Teresa E Seeman; Ana V Diez Roux
Journal:  Psychoneuroendocrinology       Date:  2018-12-07       Impact factor: 4.905

6.  Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults.

Authors:  Audrey R Tyrka; Linda L Carpenter; Hung-Teh Kao; Barbara Porton; Noah S Philip; Samuel J Ridout; Kathryn K Ridout; Lawrence H Price
Journal:  Exp Gerontol       Date:  2015-04-03       Impact factor: 4.032

Review 7.  Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging.

Authors:  Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz
Journal:  Neurosci Biobehav Rev       Date:  2015-05-18       Impact factor: 8.989

Review 8.  Accelerating research on biological aging and mental health: Current challenges and future directions.

Authors:  Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard
Journal:  Psychoneuroendocrinology       Date:  2019-04-05       Impact factor: 4.905

9.  A scoping systematic review of social stressors and various measures of telomere length across the life course.

Authors:  Margaret Willis; Shaina N Reid; Esteban Calvo; Ursula M Staudinger; Pam Factor-Litvak
Journal:  Ageing Res Rev       Date:  2018-07-23       Impact factor: 10.895

10.  Lipopolysaccharide-Induced Behavioral Alterations Are Alleviated by Sodium Phenylbutyrate via Attenuation of Oxidative Stress and Neuroinflammatory Cascade.

Authors:  Ashok Jangra; Chandra Shaker Sriram; Mangala Lahkar
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.